Elevated focal adhesion kinase expression facilitates oral tumor cell invasion

Cancer

Volumn 95, Issue 12, 2002, Pages 2508-2515

  Schneider, Galen B ^a   Kurago, Zoya ^a   Zaharias, Rebecca ^a   Gruman, Lynn M ^b   Schaller, Michael D ^c   Hendrix, Mary J C ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Carcinoma; Focal adhesion kinase; Invasion; Metastasis; Oral

Indexed keywords

FOCAL ADHESION KINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CARCINOMA IN SITU; CARCINOMA, VERRUCOUS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; IMMUNOENZYME TECHNIQUES; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037114706     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10992     Document Type: Article

References (38)

1. National Institute of Dental and Craniofacial Research: National Institutes of Health (United States). Oral cancer - confronting the enemy. Bethesda: National Institute of Dental and Craniofacial Research: National Institutes of Health, 1999.
2. Anonymous. Preventing and controlling oral and pharyngeal cancer. Recommendations from a national strategic planning conference. Morbid Mortal Weekly Rep. 1998; 47(RR-14):1-12.
3. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-626.
4. Xu LH, Yang X, Bradham CA, et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem. 2000;275:30597-30604.
5. Xu LH, Yang X, Craven RI, Cance WG. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Diff. 1998;9;999-1005.
6. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. p125FNK a structurally distinctive proteintyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA. 1992;89:5192-5196.
7. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Deu Biol. 1996; 12: 463-519.
8. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J Cell Biol. 1992;119:893-903.
9. Guan JL, Trevithick JE, Hynes RO. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 1991;2:951-964.
10. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem. 1992;267:23439-23442.
11. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. Focal adhesion kinase and paxilline bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol. 1995;130: 1181-1187.
12. Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochem Biophys Acta. 2001;1540:1-21.
13. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Progr Biophys Mol Biol. 1999;71:435-478.
14. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppresses p53-mediated apoptosis. J Cell Biol. 1998;143:547-560.
15. Frisch S, Vuori K, Ruoslahti E, Chan-Hui P. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996;134:793-799.
16. Almeida EA, Ilic D, Han Q, et al. Matrix survival signaling. From fibronectin via focal adhesion kinase to c-jun nh(2)-terminal kinase. J Cell Biol. 2000;149:741-754.
17. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol. 1996;135:1383-1390.
18. Ilic D, Furuta Y, Kanazawa S, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 1995;377:539-544.
19. Gilmore AP, Romer LH. Inhibition of FAK signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell. 1996;7:1209-1224.
20. Parsons IT, Martin KH, Slack JK, Taylor JM, Weed SA. Focal adhesion kinase: A regulator of focal adhesion dynamics and cell movement. Oncogene. 2000;19:5606-5613.
21. Kornberg LJ. Focal adhesion kinase expression in oral cancers. Head Neck. 1998;20:634-639.
22. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 1993;342:1024-1025.
23. Owens LV, Xu L, Craven RJ, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 1995;55:2752-2755.
24. Glukhova M, Koteliansky V, Sastre X, Thiery JP. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol. 1995;146:706-716.
25. Owens LV, Xu L, Dent GA, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol. 1996;3:100-105.
26. Tremblay L, Hauck W, Aprikian LR, Chapelaine A, Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50csk in human metastatic prostate carcinoma. Int J Cancer. 1996;68:164-171.
27. Han NM, Fleming RY, Curley SA, Gallick GE. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-scr or c-yes activation. Ann Surg Oncol. 1997;4:264-268.
28. Withers BE, Hanks SK, Fry DW. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells. Cancer Biochem Biophys. 1996;15:127-139.
29. Cance WG, Harris JE, Iacocca MV, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417-2423.
30. Johnson GK, Poore TK, Payne JB, Organ CC. Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1. J Periodontol. 1996;67: 116-124.
31. Lyons PD, Dunty JM, Schaefer EM, Schaller MD. Inhibition of the catalytic activity of cell adhesion kinase beta by protein tyrosine phosphatase-PEST mediated dephosphorylation. J Biol Chem. 2001;276:24422-24431.
32. Hendrix MJ, Seftor EA, Sefto, RE, Fidler IJ. A simple quantitative assay for studying the invasive potential of high an low human metastatic variants. Cancer Lett. 1987;38:137-147.
33. Ilic D, Genbacev O, Jin F, et al. Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. Am J Pathol. 2001;159:93-108.
34. Chu Y, Seftor E, Romer L, Hendrix MJC. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol. 1996;148:63-69.
35. Sieg D, Hauch C, Ilic D, et al. FAK integrates growth factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2:249-256.
36. Jones G, Machado J, Merlo A. Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of NH-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res. 2001; 61:4978-4981.
37. Hauck C, Sieg D, Hsia D, et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor stimulated signaling promoting the migration of invasive carcinoma cells. Cancer Res. 2001;61:7079-7090.
38. Sein T, Thant A, Hiraiwa Y, et al. A role for FAK I the concanavalin A-dependent secretion of matrix metalloproteinases-2 and -9. Oncogene. 2000;19:5539-5542.